Navigation Links
Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference
Date:6/23/2008

ing statements. Forward-looking statements are inherently speculative, and actual results may differ materially from Pharsight's expectations due to a variety of factors, including: changes in FDA regulations may affect the demand for the product; and customers may not perceive the benefits of the product to be the same as Pharsight believes them to be. Other risk factors relating to Pharsight are disclosed in the company's most recent Form 10-Q filed with the Securities and Exchange Commission on February 14, 2008. All forward-looking statements are based on information available to the company on the date hereof, and the company assumes no obligation to update such statements.

Registered Trademarks and Trademarks

Pharsight, WinNonlin, and IVIVC Toolkit are trademarks or registered trademarks of Pharsight Corporation. All other brand and product names are trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharsight Achieves First License Sale for Public-Source Database
2. Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
3. Pharsight Expands Strategic Consulting Services Team
4. Pharsight Hosts Fourth Annual PKS User Group Meeting
5. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
6. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
7. Pharsight Announces 1-For-3 Reverse Stock Split
8. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
9. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
10. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
11. Pharsight Achieves $7.4 Million in Quarterly Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), ... of regenerative medicine, today announced that the Company,s ... complete cervical spinal cord injury (SCI), has been ... Projects to Watch" by Elsevier Business Intelligence. ... industry honor, which represents independent validation of the ...
(Date:11/17/2014)... 17, 2014 Soligenix, Inc. (OTCQB: SNGX) ... developing products that address unmet medical needs in ... today the formation of a Medical Advisory Board ... Company as it advances the Phase 3 clinical ... of cutaneous T-cell lymphoma (CTCL), a rare class ...
(Date:11/15/2014)... As part of an ongoing ... in its network and logistics capabilities to meet ... the complex requirements of the industry. , The ... logistics and transportation, and includes opening new QuickSTAT ... will be an emphasis on Customer Service capabilities, ...
(Date:11/15/2014)... Phoenix, AZ (PRWEB) November 14, 2014 ... the DNA analysis market has already proven itself as ... consumer usage. DNA Spectrum recognizes this opportunity with its ... provides customers with a comprehensive genealogical history for a ... myDNA Safe storage service and forthcoming ...
Breaking Biology Technology:Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 2Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 3Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 4Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 5Soligenix Announces Formation of Cutaneous T-Cell Lymphoma Medical Advisory Board 6QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences 2DNA Spectrum Begins the Search For a New Chief Executive Officer 2DNA Spectrum Begins the Search For a New Chief Executive Officer 3
... ATLANTA, Sept. 5 CryoLife, Inc. (NYSE: ... company, announced,today that D. Ashley Lee, executive vice ... CryoLife, Inc., is scheduled to present at,the Bear ... 10,2007 at 4:30 p.m. EDT. Mr. Lee will ...
... Therapy Regulatory Consultant and Cryopreservation Expert, BOTHELL, ... Board: BLFS), a leading developer and marketer of,proprietary ... and organs, today announced the expansion of its ... leading experts in cell,therapy quality and regulatory assurance ...
... today at European Society of Cardiology Congress ... ... Therapeutics,Inc. (Nasdaq: CVTX ) announced today that data published in Circulation ... that Ranexa(R) (ranolazine extended-release tablets) reduced,both ventricular and atrial arrhythmias in patients ...
Cached Biology Technology:BioLife Solutions Expands Scientific Advisory Board 2BioLife Solutions Expands Scientific Advisory Board 3BioLife Solutions Expands Scientific Advisory Board 4Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R) 2Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R) 3Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R) 4
(Date:11/6/2014)... because of metastasis, yet progress in preventing and ... "It,s been particularly challenging to design drugs that ... in systems biology at Harvard Medical School. ... they,ve already metastasized." , Gujral and colleagues have ... researchers better understand how metastasis begins. Their findings ...
(Date:11/5/2014)... RENO – Kelly Redmond has dedicated his career ... knowledge to a general audience. , As deputy ... Climate Center at Nevada,s Desert Research Institute, Redmond ... the management, application and dissemination of climate data ... Annual Fall Meeting in San Francisco on December ...
(Date:11/4/2014)... of Medicine announced today that it is a ... the Bill & Melinda Gates Foundation. Laura ... Reproductive Sciences; and Vice Chair of Research and ... will pursue an innovative global health and development ... Fetal Neurodevelopment.", Grand Challenges Explorations (GCE) funds individuals ...
Breaking Biology News(10 mins):Migration negation 2Migration negation 3Nevada climatologist to be honored at AGU Fall Meeting for lifetime of public outreach 2Temple University School of Medicine receives Grand Challenges Explorations grant 2
... MA (5/18/2011) Carbon found within ancient rocks has played ... of biological life on the planet billions of years ago. ... northern Canada has revealed the carbon-based minerals may be much ... report in the latest edition of the journal Nature ...
... Forest Service (USFS) Rocky Mountain Research Station, has developed a ... on local wetland features and characteristics of the landscape surrounding ... fate of wetland habitats over a 13-state area in the ... Ecological Applications . "Because conservation resources are scarce, ...
... team of scientists from Genome Institute of Singapore (GIS) ... have shown how proteins involved in controlling genes work ... and demonstrated for the very first time, how they ... cells. The work highlighted the collaborative nature of ...
Cached Biology News:Young graphite in old rocks challenges the earliest signs of life 2New study predicts risk of wetland habitat loss in southern United States 2New study predicts risk of wetland habitat loss in southern United States 3Scientists discover switch to speed up stem cell production 2Scientists discover switch to speed up stem cell production 3
Mouse VEGF R1/Flt-1 Phycoerythrin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Affinity Purified Anti-Human NP-1...
Mouse Anti-Amyloid beta [1-16], clone 6E10, Monoclonal Antibody...
HES-1 [Hairy 1], Available Summer 2003...
Biology Products: